Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis
Ofir Elalouf, Ori Elkayam Department of Rheumatology, Sackler Faculty of Medicine, Tel Aviv Medical Center, Tel Aviv, Israel Abstract: The introduction of TNFα blockers has revolutionized the treatment of ankylosing spondylitis (AS). The objectives of this review are to summarize the most...
Saved in:
Main Authors: | Elalouf O (Author), Elkayam O (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab
by: E. Filippucci, et al.
Published: (2011) -
Short-Term Efficacy and Safety of Secukinumab for Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of RCTs
by: Yu Zhou, et al.
Published: (2020) -
Evolution of Juvenile Ankylosing Spondylitis
by: Ye.V. Prohorov, et al.
Published: (2012) -
Physiotherapy in ankylosing spondylitis
by: Kamila Balcerska, et al.
Published: (2018) -
Physiotherapy in ankylosing spondylitis
by: Kamila Balcerska, et al.
Published: (2018)